Non-Hodgkin’s lymphoma: A case of testis lymphoma metastasized to the gallbladder
Yutaka Tsutsumi, Reiki Ogasawara, Fumiyasu Yamamoto, Yutaka Yamada, Yasuyuki Komatsu, Kazuhiko Ichiki, Shinich Ito, Nobuaki Kurauchi, Kazuhiro Kudo, Norihiko Shimoyama, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Hirohito Naruse, Nobuo Masauzi
Department of Clinical Pathology, Hakodate Municipal Hospital, Hakodate, Japan.
Department of Gastroentelology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Department of Gastroenterology, Hakodate Municipal Hospital, Hakodate, Japan.
Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan.
Department of Surgery, Hakodate Municipal Hospital, Hakodate, Japan.
Department of Urology, Hakodate Municipal Hospital, Hakodate, Japan.
DOI: 10.4236/ojim.2012.21003   PDF    HTML     4,240 Downloads   7,154 Views   Citations

Abstract

Testis lymphoma (diffuse large B cell lymphoma) metastasized to the gallbladder. The gall bladder is rarely involved in cases of the malignant lymphoma, and lymphoma metastasis from the testis to the gallbladder has not been previously reported. These reports may possibly change by the introduction of PET/CT. Furthermore, although it was a struggle to diagnose this particular case, there is a possibility that we may have been able to recognize metastasis from the testis at an earlier stage if PET/CT had been conducted.

Share and Cite:

Tsutsumi, Y. , Ogasawara, R. , Yamamoto, F. , Yamada, Y. , Komatsu, Y. , Ichiki, K. , Ito, S. , Kurauchi, N. , Kudo, K. , Shimoyama, N. , Tanaka, J. , Asaka, M. , Imamura, M. , Naruse, H. and Masauzi, N. (2012) Non-Hodgkin’s lymphoma: A case of testis lymphoma metastasized to the gallbladder. Open Journal of Internal Medicine, 2, 11-14. doi: 10.4236/ojim.2012.21003.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Zucca, E., Conconi, A., Mughal, T.I., et al. (2003) Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group. Journal of Clinical Oncology, 21, 20-27. doi:10.1200/JCO.2003.11.141
[2] Mitropoulous, F.A., Angelopoulou, M.P., Siakantaris, G.R., et al. (2000) Primary non-Hodgkin’s lymphoma of the gallbladder. Leukemia & Lymphoma, 40, 123-131.
[3] Repine, T.B., DeArmond, G. and Lopez, J.D. (2004) Burkitt’s lymphoma involving the gallbladder. Journal of Clinical Oncology, 22, 5014-5015. doi:10.1200/JCO.2004.11.026
[4] Minamimoto, R., Senda, M., Terauchi, T., et al. (2010) Analysis of various malignant neoplasm detected by FDG-PET cancer screening program: Based on a Japanese Nationwide Survey. Annals of Nuclear Medicine, 17, 45-54.
[5] Michaellet, A.S., Trotman, J. and Tychyl-Pinel, C. (2010) Role of early PET in the management of diffuse large B cell lymphoma. Current Opinion in Oncology, 22, 414-418. doi:10.1097/CCO.0b013e32833d5905
[6] Lin, C., Itti, E., Haioun, C., et al. (2007) Early 18F-FDG PET for Prediction of Prognosis in Patients with diffuse large B cell lymphoma: SUV-based assessment versus visual analysis. Journal of Nuclear Medicine, 10, 1626-1632.
[7] Ng, A.P., Seymour, J.F., Lee, M., et al. (2007) Early therapeutic response assessment by (18) FDG-positron emission tomography during chemotherapy I patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure. Leukemia & Lymphoma, 48, 596-600. doi:10.1080/10428190601099965
[8] Gardini, A., Saragori, L., La Barba, G., et al. (2009) Simultaneous occurrence of primary diffuse large B cell lymphoma and extranodal marginal zone (MALT) B-cell lymphoma in the gallbladder: A case report. Pathologica, 101, 230-234.
[9] Mani, H., Climent, F., Colomo, L., et al. (2010) Gall bladder and extra hepatic bile duct lymphomas: Clinicopathological observations and biological implications. Am Journal of Surgical Pathology, 34, 1277-1286. doi:10.1097/PAS.0b013e3181e9bb8b
[10] Schoder, H., Noy, A., Gonen, M., et al. (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 23, 4643-4651. doi:10.1200/JCO.2005.12.072

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.